Valuations for GP premises sustainability loan in Scotland circulated

Valuations for GP premises sustainability loan in Scotland circulated

July 25 2018 New valuations for GP premises in Scotland have been circulated to health boards for...

Doctors reminded to preserve patient records for UK Infected Blood Inquiry

Doctors reminded to preserve patient records for UK Infected Blood Inquiry

July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be...

NAO gives NHS vanguards a mixed review

NAO gives NHS vanguards a mixed review

July 2 2018 The NHS vanguard programme “has not delivered the depth and scale of...

Scotland to expand international recruitment for doctors and nurses

Scotland to expand international recruitment for doctors and nurses

June 22 2018 Activity to recruit doctors, nurses and other specialist health staff will be...

GP trainee round 1 recruitment increases 10%

GP trainee round 1 recruitment increases 10%

June 19 2018 Over 3,000 doctors have been recruited under the current Round 1 GP trainee...

  • Valuations for GP premises sustainability loan in Scotland circulated

    Valuations for GP premises sustainability loan in Scotland circulated

    Wednesday, 25 July 2018 14:03
  • Doctors reminded to preserve patient records for UK Infected Blood Inquiry

    Doctors reminded to preserve patient records for UK Infected Blood Inquiry

    Friday, 20 July 2018 14:51
  • NAO gives NHS vanguards a mixed review

    NAO gives NHS vanguards a mixed review

    Monday, 02 July 2018 16:45
  • Scotland to expand international recruitment for doctors and nurses

    Scotland to expand international recruitment for doctors and nurses

    Friday, 22 June 2018 16:07
  • GP trainee round 1 recruitment increases 10%

    GP trainee round 1 recruitment increases 10%

    Tuesday, 19 June 2018 17:53

a doctor in consultation imageFebruary 9 2018

Precautions around the use of dopaminergic drugs in Parkinson’s disease are included in a new NICE Quality Standard. 


One of the five quality statements in QS 164 says that patients receiving dopaminergic therapy should be given advice about the risk of developing impulse control disorders. The quality statement has been included as “dopaminergic therapy, especially with dopamine agonists, is associated with a risk of developing impulse control disorders,” says NICE.

“It is important to discuss this risk and provide information to adults with Parkinson's disease, and their family members and carers, when starting treatment and at least annually. This will help them to recognise the symptoms and know where to get help if these develop.”

NICE expects healthcare professionals to “provide oral and written information about the risk of developing impulse control disorders to adults with Parkinson's disease when starting dopaminergic therapy (not just dopamine agonists) and discuss this with them at least annually.” They should also provide information for family members and carers if appropriate.

In addition, “oral and written information should be given about:

  • the different types of impulse control disorders (for example, compulsive gambling, hypersexuality, binge eating and obsessive shopping);
  • the increased risk of impulse control disorders developing with dopamine agonists;
  • the risk that impulse control disorders may be concealed by the person affected;
  • who to contact if impulse control disorders develop;
  • the possibility that if problematic impulse control disorders develop, dopamine agonist therapy will be reviewed and may be reduced or stopped.”

A sperate quality statement says that patients should have a point of contact with specialist services. They should also be “referred to physiotherapy, occupational therapy or speech and language therapy if they have problems with balance, motor function, activities of daily living, communication, swallowing or saliva.”

This means GPs and others need to be “aware of local referral pathways to physiotherapy, occupational therapy and speech and language therapy for adults with Parkinson’s disease.” Healthcare professionals should “carry out regular assessments of balance, motor function, activities of daily living, communication, swallowing and saliva for adults with Parkinson’s disease and refer them for physiotherapy, occupational therapy or speech and language therapy specific for Parkinson’s disease if problems are identified.”

A further quality statement says patients should have access to clozapine and patient monitoring for treating hallucinations and delusions.

The Quality Standards should be used alongside NICE guideline NG71 on Parkinson’s disease in adults.

Links:
NICE QS 164 Parkinson’s Disease           
NICE Guideline on Parkinson’s disease in adults NG71   

Management News

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect them from cancer, the Department of Health and Social Care has announced.
July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...